|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Coagulase negative Staphylococcus (CONS), once considered as a commensal has now evolved as a major infectious pathogen with biofilm forming ability. This study was conducted to identify the antibiotic resistance pattern of varied CONS species in association with its biofilm forming ability. CONS isolated from various clinical samples were speciated. Their antimicrobial resistant pattern and biofilm producing ability were studied and analyzed. 7.98% of our clinical isolates were CONS, with 21.52% of them being Methicillin resistant (MR-CONS) and 78.48% were Methicillin sensitive (MS-CONS). Of the MR-CONS, S. epidermidis comprises about 70.59%, followed by S. hemolyticus (15.69%). 23.63 % of CONS are biofilm producers, of which 60.71% are MR-CONS isolates and 39.29% were MS –CONS. 73.21% of biofilm producers were S. epidermidis. Biofilm producers were resistant to multiple antibiotics when compared to non-biofilm producers. All the CONS isolates were sensitive to vancomycin and Linezolid. With increase in incidence of MR-CONS and biofilm formation, routine identification with their antimicrobial resistance pattern should be documented and practiced to prevent the emergence of these common commensals as super bugs.